CTTI Annual Report

CTTI Annual Report

CTTI 2025 Annual Report:

Bridging Vision & Impact

As we reflect on another dynamic year, we are fortunate to be part of CTTI. From our distinct vantage points, we see several factors shaping the clinical trials enterprise:

  • Accelerations in federal activities to achieve valuable clinical interventions, fair pricing and affordability, and direct consumer access
  • Deceleration of federal investment in scientific and clinical research, economic headwinds, and the offshoring of research investments
  • Regulatory focus on transparency, faster development and review, and common-sense flexibility in evidentiary standards

Seizing a transformation of this scale takes collaboration and bold leadership, and throughout the year you, our members, and the broader community brought candor, experience, and creativity to understanding the impacts and opportunities ahead. This report highlights the 2025 conversations you shaped with us and accomplishments you made possible. It also encourages you to think boldly about 2026: What assumptions should we challenge, and what change can we spark together?

With appreciation,

John, Khair, Mark
CTTI Executive Committee Co-chairs

CTTI Leading

Advancing Innovative Solutions

This year, CTTI’s project teams addressed critical quality and efficiency challenges, from streamlining trial design to improving coordination and readiness across clinical trial sectors. With a common-sense ‘totality of evidence’ approach, CTTI is co-creating a research ecosystem that delivers better, faster, and more accessible evidence to improve health for all.

SEE HOW We're advancing solutions

CTTI_projects_20nov2025-2
CTTI_charting path_20nov2025

CTTI Community

Convening For Impact

In 2025, CTTI focused on bringing together leaders, patients, and partners for a series of high-impact convenings, including the inaugural State of Clinical Trials meeting, two salon dinners, the fall Steering Committee meeting, and a second AI convening with the FDA. Across these forums, participants tackled urgent challenges and opportunities in clinical research, from real-world data and decentralized models to AI integration, safety reporting, and regulatory modernization. Given evolving national priorities and rapidly advancing technological capabilities, we focused on creating connections across organizations and disciplines to spark new ideas and enhance collective learning.

SEE WHERE We convened this year

CTTI Directions

Looking Ahead

In the year ahead, CTTI’s work will be guided by key questions that define the future of evidence generation: How will AI/ML reshape clinical development? How can every involved party accelerate uptake of common-sense regulatory flexibilities? How do we design studies that satisfy country-level enrollment expectations, maintain sufficient generalizability, and still go fast? By confronting these critical and urgent questions together, CTTI members and the broader enterprise are charting the path to a modern evidence generation system.

FIND OUT What's next for CTTI

CTTI_projects_20nov2025-1

Driving Change Across Clinical Trials

Since 2007, CTTI has transformed the clinical trials landscape. Through comprehensive recommendations, practical tools, insightful case studies, and impactful publications and presentations, we continue to drive innovation and improve accessibility across the clinical research enterprise.

metric_one_06dec2025
metric_two_06dec2025
metric_three_06dec2025
metric_four_06dec2025
metric_five_06dec2025